A detailed history of Longbow Finance Sa transactions in Eli Lilly & CO stock. As of the latest transaction made, Longbow Finance Sa holds 23,877 shares of LLY stock, worth $19.2 Million. This represents 2.23% of its overall portfolio holdings.

Number of Shares
23,877
Previous 25,205 5.27%
Holding current value
$19.2 Million
Previous $19.6 Billion 10.25%
% of portfolio
2.23%
Previous 1.98%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $962,627 - $1.21 Million
-1,328 Reduced 5.27%
23,877 $21.6 Billion
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $6.31 Million - $8.45 Million
10,662 Added 73.31%
25,205 $19.6 Billion
Q4 2023

Feb 08, 2024

SELL
$525.19 - $619.13 $1.47 Million - $1.73 Million
-2,802 Reduced 16.15%
14,543 $8.48 Billion
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $25,647 - $35,358
-59 Reduced 0.34%
17,345 $9.32 Billion
Q2 2023

Nov 13, 2023

BUY
$350.74 - $468.98 $6.1 Million - $8.16 Million
17,404 New
17,404 $8.16 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Longbow Finance Sa Portfolio

Follow Longbow Finance Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Longbow Finance Sa, based on Form 13F filings with the SEC.

News

Stay updated on Longbow Finance Sa with notifications on news.